| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0049 | 0.9 |